Skip to main content
Center for Cell and Gene Therapy
Dr. Peggy Goodell elected to National Academy of Medicine - OCT 21, 2019 Dr. Margaret “Peggy” Goodell, chair of the Department of Molecular and Cellular Biology at Baylor College of Medicine, has been elected to the National Academy of Medicine.
Baylor faculty elected National Academy of Inventors fellows - DEC 12, 2018 Drs. Mary K. Estes, Bert O’Malley and Huda Zoghbi of Baylor College of Medicine were three of the 148 renowned academic inventors named fellows of the National Academy of Inventors this week.
$5 million grant to expand blood cancer therapy options - OCT 18, 2018 Using a new grant from the Leukemia and Lymphoma Society, a team from Baylor College of Medicine will work to develop more widely applicable targeted cellular therapies for leukemia and lymphoma.
Engineered T cells made to recognize tumor-specific patterns - JUN 26, 2018 Researchers have found a new way to ensure that engineered T cells can reliably discriminate between normal and malignant cells.
Immunotherapy summit brings together patients, experts - JAN 11, 2018 The NCI-designated Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine is hosting a free educational program for cancer patients and their caregivers seeking to learn more about cancer immunotherapy and clinical trials.
Two Baylor College of Medicine faculty members named to National Academy of Medicine - OCT 17, 2016 Dr. Malcolm Brenner and Dr. Cheryl Walker were elected to membership in the National Academy of Medicine.
Special T cells that target solid tumors offer potential treatment for pediatric and adult cancers - SEP 14, 2016 A new study by researchers at Baylor College of Medicine and Texas Children’s Cancer Center has shown promising results for the use of adoptive cell-therapies to treat pediatric and adult solid tumor cancers.
One-time treatment rescues lethal metabolic liver disease in mice - AUG 30, 2016 Researchers have shown in mice that deleting a gene associated with liver disorder tyrosinaemia type I, they can turn the once deadly illness benign.
T cells that target two tumor surface molecules mitigate tumor escape in mouse model of glioblastoma - JUL 18, 2016 Researchers show a new strategy, based on targeting specific surface molecules, that eliminates most of the cancer cells in a mouse model of glioblastoma.
Baylor, Cell Medica announce groundbreaking collaboration to create cellular immunotherapy products for cancer treatment - JUN 17, 2016 Baylor, Cell Medica enter landmark sponsored research collaboration, representing a significant milestone in an effort to develop a new class of life-saving cancer therapy.
Targeting B-cell malignancies with κ-specific T cells can lead to complete clinical responses - JUN 6, 2016 Treating B cell malignancies with the patients’ own T cells modified so as to target specific B cell markers has shown clinical success.
Discovery of CTLA-4 in dendritic cells opens new possibilities to fight cancer - APR 4, 2016 Baylor College of Medicine researchers have discovered that CTLA-4 is produced and secreted by dendritic cells, which are the ‘generals’ of the T cells in the battle against cancer.
Heslop named director of Center for Cell and Gene Therapy - APR 1, 2016 The Baylor College of Medicine Board of Trustees named Dr. Helen Heslop as director of the Center for Cell and Gene Therapy.
Grants support Baylor researchers’ work on immunotherapy for leukemia - OCT 2, 2015 Two Baylor researchers have received Translational Research Grants for projects that use immunotherapy approaches to treat leukemia.
Safety switch preserves beneficial effects of cell therapy - MAY 14, 2015 Researchers have found that a single dose of an otherwise harmless drug can safely control the severe and often lethal side effects associated with haploidentical stem cell transplantation.
Novel cell therapy from 'naïve' cells recognizes, attacks high-risk viruses for first time in cord blood transplant patients - APR 29, 2015 Virus-specific cell therapy used in cord blood transplant patients successfully prevented 3 of the most problematic post-transplant viruses affecting this group of patients – cytomegalovirus, Epstein-Barr virus, and adenovirus.
Grant supports research on potential immunotherapy treatment for neuroblastoma - DEC 30, 2014 Dr. Leonid Metelitsa, named among inaugural recipients of the Bio-therapeutics Impact Award from Alex’s Lemonade Stand.
Developmental transcription factors oversee glioma sub-types - OCT 6, 2014 Researchers find transcription factors NFIA, Sox10 play important roles in the development of different subtypes of deadly brain tumors.
Dr. Malcolm Brenner receives prestigious lifetime achievement honor from Human Gene Therapy journal - AUG 5, 2014 Renowned cell and gene therapy clinician-scientist Dr. Malcolm Brenner has received the prestigious Pioneer Award from the journal Human Gene Therapy.
New study advances safety, efficacy profile of virus-specific T cells for post-transplant recipients - JUN 25, 2014 Using specialized, virus-specific immune cells called T cells, researchers have identified a novel safe, effective and rapid approach to protect from the threat of multiple severe infections at once.